These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37391240)

  • 1. Erratum to: Park J, Venkatesulu BP, Kujundzic K, Katsoulakis E, Solanki AA, Puckett LL, Kapoor R, Chapman CH, Hagan M, Kelly MD, Palta J, Ashman JB, Jacqmin D, Kachnic LA, Minsky BD, Olsen J, Raldow AC, Wo JY, Dawes S, Wilson E, Kudner R, Das P. Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel. Pract Radiat Oncol 2022;12:424-436.
    Pract Radiat Oncol; 2023; 13(4):370-375. PubMed ID: 37391240
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to: Park J, Puckett LL, Katsoulakis E, Venkatesulu BP, Kujundzic K, Solanki AA, Movsas B, Simone CB 2nd, Sandler H, Lawton CA, Das P, Wo JY, Buchholz TA, Fisher CM, Harrison LB, Sher DJ, Kapoor R, Chapman CH, Dawes S, Kudner R, Wilson E, Hagan M, Palta J, Kelly MD. Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative. Pract Radiat Oncol 2022;12:468-474.
    Pract Radiat Oncol; 2023; 13(4):366-369. PubMed ID: 37391239
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to: Katsoulakis E, Kudner R, Chapman C, et al. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel. Pract Radiat Oncol. 2022; 12(5):409-423.
    Pract Radiat Oncol; 2023; 13(5):e460-e469. PubMed ID: 37652624
    [No Abstract]   [Full Text] [Related]  

  • 4. Consensus Quality Measures and Dose Constraints for Rectal Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology (ASTRO) Expert Panel.
    Park J; Venkatesulu BP; Kujundzic K; Katsoulakis E; Solanki AA; Puckett LL; Kapoor R; Chapman CH; Hagan M; Kelly MD; Palta J; Ashman JB; Jacqmin D; Kachnic LA; Minsky BD; Olsen J; Raldow AC; Wo JY; Dawes S; Wilson E; Kudner R; Das P
    Pract Radiat Oncol; 2022; 12(5):424-436. PubMed ID: 35907764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus Quality Measures and Dose Constraints for Lung Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and ASTRO Expert Panel.
    Puckett LL; Titi M; Kujundzic K; Dawes SL; Gore EM; Katsoulakis E; Park JH; Solanki AA; Kapoor R; Kelly M; Palta J; Chetty IJ; Jabbour SK; Liao Z; Movsas B; Thomas CR; Timmerman RD; Werner-Wasik M; Kudner R; Wilson E; Simone CB
    Pract Radiat Oncol; 2023; 13(5):413-428. PubMed ID: 37075838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Consensus Quality Measures and Dose Constraints for Breast Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
    Puckett LL; Kodali D; Solanki AA; Park JH; Katsoulakis E; Kudner R; Kapoor R; Kujundzic K; Chapman CH; Hagan M; Kelly M; Palta J; Bazan JG; Dragun A; Fisher C; Haffty B; Nichols E; Shah C; Salehpour M; Dawes S; Wilson E; Buchholz TA
    Pract Radiat Oncol; 2023; 13(3):217-230. PubMed ID: 36115498
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus Quality Measures and Dose Constraints for Prostate Cancer From the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
    Solanki AA; Puckett LL; Kujundzic K; Katsoulakis E; Park J; Kapoor R; Hagan M; Kelly M; Palta J; Ballas LK; DeMarco J; Hoffman KE; Lawton CAF; Michalski J; Potters L; Zelefsky M; Kudner R; Dawes S; Wilson E; Sandler H
    Pract Radiat Oncol; 2023; 13(2):e149-e165. PubMed ID: 36522277
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Consensus Quality Measures and Dose Constraints for Head and Neck Cancer with an emphasis on Oropharyngeal and Laryngeal Cancer from the Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Expert Panel.
    Katsoulakis E; Kudner R; Chapman C; Park J; Puckett L; Solanki A; Kapoor R; Hagan M; Kelly M; Palta J; Tishler R; Hitchcock Y; Chera B; Feygelman V; Walker G; Sher D; Kujundzic K; Wilson E; Dawes S; Yom SS; Harrison L
    Pract Radiat Oncol; 2022; 12(5):409-423. PubMed ID: 35667551
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erratum to: Trifiletti DM, Ballman KV, Brown PD, Anderson SK, Carrero XW, Cerhan JH, Whitton AC, Greenspoon J, Parney IF, Laack NN, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG II, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D. Optimizing Whole Brain Radiation Therapy Dose and Fractionation: Results From a Prospective Phase 3 Trial (NCCTG N107C [Alliance]/CEC.3). Int J Radiat Oncol Biol Phys 2020;106:255-260.
    Int J Radiat Oncol Biol Phys; 2020 Apr; 106(5):1111. PubMed ID: 32171455
    [No Abstract]   [Full Text] [Related]  

  • 10. MO-F-BRCD-02: SBRT (Part 2): Physics and Quality Assurance Updates.
    Perks J; Benedict S
    Med Phys; 2012 Jun; 39(6Part21):3873. PubMed ID: 28518227
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Erratum: Holliday EB, Siker M, Chapman CH, Jagsi R, Bitterman DS, Ahmed AA, Winkfield K, Kelly M, Tarbell NJ, Deville Jr C: Achieving Gender Equity in the Radiation Oncology Physician Workforce (Advances in Radiation Oncology 2018;3:478-483).
    Adv Radiat Oncol; 2019; 4(1):210. PubMed ID: 30706030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Veterans Affairs Radiation Oncology Quality Surveillance Program and American Society for Radiation Oncology Quality Measures Initiative.
    Park J; Puckett LL; Katsoulakis E; Venkatesulu BP; Kujundzic K; Solanki AA; Movsas B; Simone CB; Sandler H; Lawton CA; Das P; Wo JY; Buchholz TA; Fisher CM; Harrison LB; Sher DJ; Kapoor R; Chapman CH; Dawes S; Kudner R; Wilson E; Hagan M; Palta J; Kelly MD
    Pract Radiat Oncol; 2022; 12(6):468-474. PubMed ID: 35690354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erratum to: Chuong MD, Bryant J, Mittauer KE, Hall M, Kotecha R, Alvarez D, Romaguera T, Rubens M, Adamson S, Godley A, Mishra V, Luciani G, Gutierrez AN. Ablative 5-Fraction Stereotactic Magnetic Resonance-Guided Radiation Therapy With On-Table Adaptive Replanning and Elective Nodal Irradiation for Inoperable Pancreas Cancer. Pract Radiat Oncol. 2021;11:134-147.
    Pract Radiat Oncol; 2021; 11(3):e354. PubMed ID: 33941354
    [No Abstract]   [Full Text] [Related]  

  • 14. Commentary on "identification of 23 new prostate cancer susceptibility loci using the iCOGS custom genotyping array." Eeles RA, Olama AA, Benlloch S, Saunders EJ, Leongamornlert DA, Tymrakiewicz M, Ghoussaini M, Luccarini C, Dennis J, Jugurnauth-Little S, Dadaev T, Neal DE, Hamdy FC, Donovan JL, Muir K, Giles GG, Severi G, Wiklund F, Gronberg H, Haiman CA, Schumacher F, Henderson BE, Le Marchand L, Lindstrom S, Kraft P, Hunter DJ, Gapstur S, Chanock SJ, Berndt SI, Albanes D, Andriole G, Schleutker J, Weischer M, Canzian F, Riboli E, Key TJ, Travis RC, Campa D, Ingles SA, John EM, Hayes RB, Pharoah PD, Pashayan N, Khaw KT, Stanford JL, Ostrander EA, Signorello LB, Thibodeau SN, Schaid D, Maier C, Vogel W, Kibel AS, Cybulski C, Lubinski J, Cannon-Albright L, Brenner H, Park JY, Kaneva R, Batra J, Spurdle AB, Clements JA, Teixeira MR, Dicks E, Lee A, Dunning AM, Baynes C, Conroy D, Maranian MJ, Ahmed S, Govindasami K, Guy M, Wilkinson RA, Sawyer EJ, Morgan A, Dearnaley DP, Horwich A, Huddart RA, Khoo VS, Parker CC, Van As NJ, Woodhouse CJ, Thompson A, Dudderidge T, Ogden C, Cooper CS, Lophatananon A, Cox A, Southey MC, Hopper JL, English DR, Aly M, Adolfsson J, Xu J, Zheng SL, Yeager M, Kaaks R, Diver WR, Gaudet MM, Stern MC, Corral R, Joshi AD, Shahabi A, Wahlfors T, Tammela TL, Auvinen A, Virtamo J, Klarskov P, Nordestgaard BG, Røder MA, Nielsen SF, Bojesen SE, Siddiq A, Fitzgerald LM, Kolb S, Kwon EM, Karyadi DM, Blot WJ, Zheng W, Cai Q, McDonnell SK, Rinckleb AE, Drake B, Colditz G, Wokolorczyk D, Stephenson RA, Teerlink C, Muller H, Rothenbacher D, Sellers TA, Lin HY, Slavov C, Mitev V, Lose F, Srinivasan S, Maia S, Paulo P, Lange E, Cooney KA, Antoniou AC, Vincent D, Bacot F, Tessier DC; COGS-Cancer Research UK GWAS-ELLIPSE (part of GAME-ON) Initiative; Australian Prostate Cancer Bioresource; UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology; UK ProtecT (Prostate testing for cancer and Treatment) Study.
    Olumi AF
    Urol Oncol; 2014 Feb; 32(2):211. PubMed ID: 24445293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. VA-Radiation Oncology Quality Surveillance Program.
    Hagan M; Kapoor R; Michalski J; Sandler H; Movsas B; Chetty I; Lally B; Rengan R; Robinson C; Rimner A; Simone C; Timmerman R; Zelefsky M; DeMarco J; Hamstra D; Lawton C; Potters L; Valicenti R; Mutic S; Bosch W; Abraham C; Caruthers D; Brame R; Palta JR; Sleeman W; Nalluri J
    Int J Radiat Oncol Biol Phys; 2020 Mar; 106(3):639-647. PubMed ID: 31983560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Erratum to: Worrell SG, Goodman KA, Altorki NK, et al. The Society of Thoracic Surgeons/American Society for Radiation Oncology Updated Clinical Practice Guidelines on Multimodality Therapy for Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction. Pract Radiat Oncol. 2024;14:28-46.
    Pract Radiat Oncol; 2024; 14(2):172. PubMed ID: 38185278
    [No Abstract]   [Full Text] [Related]  

  • 17. Erratum for Dominello MM, Sanders T, Anscher M, et al. "Responses to the 2018 and 2019 "One Big Discovery" Question: ASTRO Membership's Opinions on the Most Important Research Question Facing Radiation Oncology…Where Are We Headed?" Int J Radiat Oncol Biol Phys 2021;109:38-40.
    Int J Radiat Oncol Biol Phys; 2023 Jun; 116(2):471. PubMed ID: 37179101
    [No Abstract]   [Full Text] [Related]  

  • 18. Erratum to: Fung CY, Chen E, Vapiwala N, et al. The American Society for Radiation Oncology 2017 Radiation Oncologist Workforce Study. Int J Radiat Oncol Biol Phys 2019;103:547-556.
    Int J Radiat Oncol Biol Phys; 2019 May; 104(1):226. PubMed ID: 30967235
    [No Abstract]   [Full Text] [Related]  

  • 19. Erratum to: Tward, J; Lenz, L; Flake II, DD; Rajamani, S; Yonover, P; Olsson, C; Kapoor, DA; Mantz, C; Liauw, SL; Antic, T; Fabrizio, M; Salzstein, D; Shore, N; Albertson, D; Henderson, J; Lee, SP; Gay, HA; Michalski, J; Hung, A; Raben, D; Garraway, I; Lewis, MS; Nguyen, PL; Marshall, DT; Brawer, MK; Stone, S; Cohen, T. The clinical cell-cycle risk (CCR) score is associated with metastasis after radiation therapy and provides guidance on when to forgo combined androgen deprivation therapy with dose-escalated radiation. Int J Radiat Oncol Biol Phys 2022;113:66-76. doi.org/10.1016/j.ijrobp.2021.09.034.
    Int J Radiat Oncol Biol Phys; 2023 Feb; 115(2):543. PubMed ID: 36621237
    [No Abstract]   [Full Text] [Related]  

  • 20. Erratum to: Wallner PE, Anscher MS, Barker CA, et al. Current status and recommendations for the future of research, teaching, and testing in the biological sciences of radiation oncology: report of the American Society for Radiation Oncology Cancer Biology/Radiation Biology Task Force, executive summary. Int J Radiat Oncol Biol Phys 2014;88:11-17.
    Int J Radiat Oncol Biol Phys; 2015 Apr; 91(5):1115. PubMed ID: 25832710
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.